Cellectis (CLLS) Depreciation & Amortization (CF) (2015 - 2026)
Cellectis' Depreciation & Amortization (CF) was $4.41 million in Q2 2026, down 12.1% from $5.02 million a year earlier and down 2.7% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Cellectis' Depreciation & Amortization (CF) was $19.06 million through Jun 30, 2026, down 7.0% year-over-year; for FY2025, it came in at $20.06 million, up 1.1% from FY2024.
- Depreciation & Amortization (CF) has now increased for seven consecutive years, with a five-year compound annual growth rate of 20.7% (FY2020 to FY2025).
- In earlier years, Depreciation & Amortization (CF) was $19.85 million in FY2024 (+7.1%), $18.52 million in FY2023 (+0.5%), $18.44 million in FY2022 (+30.2%) and $14.16 million in FY2021 (+80.7%).
- The Q2 2026 figure marks the lowest quarterly Depreciation & Amortization (CF) since Q3 2022.
- Compared with a year earlier, Depreciation & Amortization (CF) has declined for three straight quarters, with growth averaging 0.7% over the last eight quarters.
- The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2021 (growth of 147.4%); the worst was Q2 2023 (a decline of 13.5%).
- Per Business Quant data, CLLS's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $4.54 million (Q1 2026), $5.1 million (Q4 2025) and $5.01 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Cellectis | 151.51 Mn | -601.88 Mn | - | 4.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.41 Mn |
| Mar 31, 2026 | 4.54 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Sep 30, 2025 | 5.01 Mn |
| Jun 30, 2025 | 5.02 Mn |
| Mar 31, 2025 | 4.93 Mn |
| Dec 31, 2024 | 5.83 Mn |
| Sep 30, 2024 | 4.72 Mn |
| Jun 30, 2024 | 4.73 Mn |
| Mar 31, 2024 | 4.57 Mn |
| Dec 31, 2023 | 5.18 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 4.42 Mn |
| Mar 31, 2023 | 4.46 Mn |
| Dec 31, 2022 | 4.73 Mn |
| Sep 30, 2022 | 4.31 Mn |
| Jun 30, 2022 | 5.11 Mn |
| Mar 31, 2022 | 4.90 Mn |
| Dec 31, 2021 | 2.62 Mn |
| Sep 30, 2021 | 4.37 Mn |
API Access
Cellectis Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();